このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Divi's Laboratories 将来の成長

Future 基準チェック /46

Divi's Laboratories利益と収益がそれぞれ年間24.1%と15%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に17.1% 22%なると予測されています。

主要情報

21.7%

収益成長率

21.8%

EPS成長率

Life Sciences 収益成長	20.8%
収益成長率	14.5%
将来の株主資本利益率	16.6%
アナリストカバレッジ	Good
最終更新日	22 Aug 2024

今後の成長に関する最新情報

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Aug 06

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Jul 19

Recent updates

Revenues Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)

Sep 06

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Aug 06

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Jul 19

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Apr 19

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02

業績と収益の成長予測

NSEI:DIVISLAB - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	121,902	30,411	18,612	N/A	13
3/31/2026	106,127	26,020	12,413	N/A	26
3/31/2025	90,982	20,595	7,442	N/A	25
6/30/2024	81,850	16,740	N/A	N/A	N/A
3/31/2024	78,450	16,000	2,580	12,610	N/A
12/31/2023	74,926	13,834	N/A	N/A	N/A
9/30/2023	73,456	13,314	7,927	15,127	N/A
6/30/2023	72,906	14,774	N/A	N/A	N/A
3/31/2023	77,670	18,240	19,860	24,590	N/A
12/31/2022	83,353	23,971	N/A	N/A	N/A
9/30/2022	91,208	29,925	22,153	28,404	N/A
6/30/2022	92,538	31,054	N/A	N/A	N/A
3/31/2022	89,599	29,605	11,986	19,118	N/A
12/31/2021	82,297	25,678	N/A	N/A	N/A
9/30/2021	74,379	21,362	4,760	13,465	N/A
6/30/2021	71,996	20,493	N/A	N/A	N/A
3/31/2021	69,695	19,843	10,367	19,469	N/A
12/31/2020	65,710	18,705	N/A	N/A	N/A
9/30/2020	62,658	17,590	10,714	20,167	N/A
6/30/2020	59,620	15,962	N/A	N/A	N/A
3/31/2020	53,945	13,765	327	12,159	N/A
12/31/2019	52,719	12,803	N/A	N/A	N/A
9/30/2019	52,356	13,106	-3,430	7,962	N/A
6/30/2019	51,139	13,575	N/A	N/A	N/A
3/31/2019	49,463	13,527	2,212	9,543	N/A
3/31/2018	38,915	8,770	N/A	7,759	N/A
3/31/2017	40,643	10,604	N/A	11,504	N/A
3/31/2016	37,764	11,258	N/A	10,379	N/A
3/31/2015	31,049	8,515	N/A	8,263	N/A
3/31/2014	25,267	7,733	N/A	5,567	N/A

アナリストによる今後の成長予測

収入対貯蓄率: DIVISLABの予測収益成長率 (年間20.6% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: DIVISLABの収益 ( 20.6% ) はIndian市場 ( 15.9% ) よりも速いペースで成長すると予測されています。

高成長収益: DIVISLABの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: DIVISLABの収益 ( 14% ) Indian市場 ( 9.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: DIVISLABの収益 ( 15% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: DIVISLABの自己資本利益率は、3年後には低くなると予測されています ( 17.1 %)。

Divi's Laboratories 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Price target increased by 9.6% to ₹4,300

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Price target increased by 11% to ₹3,806

Consensus EPS estimates fall by 10%

Price target increased by 7.3% to ₹3,325

Recent updates

Revenues Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)

Chief Technologist - PDSC recently sold ₹9.8m worth of stock

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2024

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Price target increased by 9.6% to ₹4,300

Upcoming dividend of ₹30.00 per share

Divi's Laboratories Limited to Report Q1, 2025 Results on Aug 03, 2024

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited Announces Board and Committee Changes

Insider recently sold ₹46m worth of stock

Insider recently sold ₹238m worth of stock

Dividend of ₹30.00 announced

Price target increased by 11% to ₹3,806

Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24

Divi's Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Insider recently sold ₹24m worth of stock

Chief Technologist recently sold ₹56m worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2024 Results on Feb 10, 2024

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Non-Executive Independent Director recently sold ₹1.4m worth of stock

Consensus EPS estimates fall by 10%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently sold ₹3.3m worth of stock

Chief Technologist recently sold ₹2.9m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2023

Divi's Laboratories Limited Informs Resignations of Directors

Price target increased by 7.3% to ₹3,325

New minor risk - Profit margin trend

Insufficient new directors

Divi's Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₹30.00 per share at 0.8% yield

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

New minor risk - Insider selling

Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Divi's Laboratories Limited, Annual General Meeting, Aug 28, 2023

Insider recently sold ₹3.4m worth of stock

Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹68.69 (vs ₹112 in FY 2022)

Divi's Laboratories Limited to Report Q4, 2023 Results on May 20, 2023

Insider recently sold ₹2.0m worth of stock

Global Quality Head recently sold ₹2.3m worth of stock

Global Quality Head recently sold ₹2.8m worth of stock

Global Quality Head recently sold ₹28m worth of stock

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 15%

Divi's Laboratories Limited to Report Q3, 2023 Results on Feb 03, 2023

Board Member recently sold ₹10m worth of stock

MD & Executive Director recently sold ₹1.0m worth of stock

Insider recently sold ₹1.7m worth of stock

Insider recently sold ₹1.2m worth of stock

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Price target decreased to ₹3,685

Price target decreased to ₹3,685

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Insider recently sold ₹1.5m worth of stock

Insider recently sold ₹3.7m worth of stock

Upcoming dividend of ₹30.00 per share

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00